Autism Spectrum Disorder Trial, Recruiting NCT06142955 Sponsor: Yale University Condition: Autism Spectrum Disorder
Back to Autism Spectrum Disorder

Autism Spectrum Disorder Trial, Recruiting

NCT06142955
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 40 years old and are connected to Yale University or the surrounding community, with or without a diagnosis of depression.
  • You are between 18 and 40 years old and have a diagnosis of autism spectrum disorder, autistic disorder, PDD NOS, or Asperger syndrome, with or without a diagnosis of depression.
  • If you have depression, your depression score on a standard rating scale (HDRS-17) must meet a minimum threshold of 20 (confirm with trial site).
  • You are either not taking any medications, or you have been on a stable medication routine for at least two weeks.
  • You are willing and able to take part in brain wave (EEG) and eye-tracking tests.
  • You are able and willing to sign a consent form agreeing to participate.

Who may not be able to join:

  • You have had a significant head injury or serious brain illness.
  • You are unable to sign a consent form yourself.
  • You have a major psychiatric condition, such as psychosis or bipolar disorder, that would make it difficult to complete the study.
  • You have a history of serious medical illness, stroke, seizures, abnormal brain wave patterns on an EEG, or a family history of epilepsy.
  • You are taking prescription medications that may affect the thinking or brain processes being studied.
  • You are taking any medication that could increase your risk of having a seizure.
  • You have used alcohol or recreational drugs in the 24 hours before your scheduled visit (checked by a urine test).
  • You have had a problem with substance or alcohol misuse in the past 6 months.
  • You have active thoughts of suicide, or have made a suicide attempt in the last 6 months.
  • You are pregnant, suspected to be pregnant, or test positive on a pregnancy test.
  • You have a history of working with metal or have ever been injured by metal fragments or shrapnel.
  • You have previously had TMS (a type of brain stimulation) therapy, or have taken part in a study using an experimental drug in the past 12 weeks.
  • Your IQ score is below 80, as measured by a specific intelligence test used in this study (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Sherab Tsheringla, MD, Yale University

Phone: 2032158046

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
30 April 2024
Est. completion
1 February 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in Electroencephalogram (EEG) brain responses to sad faces; Change in eye tracking (ET) to sad faces; Change in Auditory Steady State Response (ASSR)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov